- House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval https://www.nytimes.com/2021/09/02/health/aduhelm-fda.html 3 comments politics
Linking pages
- Three F.D.A. Advisers Resign Over Approval of Alzheimer's Drug - The New York Times https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html 40 comments
- In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug - The New York Times https://www.nytimes.com/2021/07/08/health/aduhelm-alzheimers-fda.html 1 comment
- How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved - The New York Times https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.html 1 comment
Linked pages
- Three F.D.A. Advisers Resign Over Approval of Alzheimer's Drug - The New York Times https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html 40 comments
- Biogen's Alzheimer’s Drug Poses a Dilemma for the F.D.A. - The New York Times https://www.nytimes.com/2021/06/05/health/alzheimers-aducanumab-fda.html 2 comments
- In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug - The New York Times https://www.nytimes.com/2021/07/08/health/aduhelm-alzheimers-fda.html 1 comment
- How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved - The New York Times https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.html 1 comment
Related searches:
Search whole site: site:www.nytimes.com
Search title: House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval - The New York Times
See how to search.